Navigation Links
New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%
Date:6/24/2009

HARRISBURG, Pa., June 25 /PRNewswire/ -- In a revolutionary healthcare finding, a peer-reviewed clinical study published in the British Journal of Nutrition (a Cambridge University Journal), clearly shows that Prebiotics reduce cholesterol and triglycerides, control body weight, and increase lifespan by 33%.

The controlled clinical study was conducted on rats and showed that the rats fed prebiotics had an 80% survival rate to 24 months versus a 50% survival rate for the control group rats that were not fed prebiotics. Additionally, the "prebiotic" rats showed material reductions in cholesterol and body weight versus the control group.

Significantly, the prebiotic used in the study was oligofructose enriched inulin, a blend of two prebiotics which has repeatedly shown synergistic health benefits versus the more common single-prebiotic fibers such as plain inulin.

"This study, clearly demonstrating life-lengthening impact of prebiotics, has truly profound implications," says Jackson GI Medical CEO Kristian Chronister. "It certainly reinforces our commitment to powering our Prebiotin prebiotic supplements with oligofructose enriched inulin despite the dramatically lower cost of plain inulin," he says.

Oligofructose enriched inulin is a 100% natural, plant-derived 'compound' prebiotic fiber which has extensive clinical research demonstrating strong health benefits. Plain inulin is a far cheaper prebiotic which is used in most prebiotic supplements and enhanced foods.

"The implications of this study are somewhat staggering," says Jackson GI Chairman and Founder Frank W. Jackson, M.D. "While the research doesn't quite yet justify a claim that Prebiotin lengthens human life, the study is nevertheless dramatic in that it clearly demonstrates the colon is a health- and life-giving organ we must nourish and cherish, not just a waste disposal system."

Prebiotics are a special class of fibers which deliver health benefits by nourishing beneficial bacteria in the digestive tract while not providing sustenance to undesirable bacteria.

"We have long known from clinical research that oligofructose enriched inulin, the prebiotic in our Prebiotin family of products, enhances immunity, increases calcium absorption, decreases heart-unfriendly triglycerides and promotes digestive health," says Chronister. "This latest study strongly suggests that a very potent overall health benefit is the net result of adding prebiotics to the diet."

A precis of the research is presented at http://www.prebiotin.com, as well as a link to the full clinical study.

    Contact
    Kristian Chronister
    717-525-7457


'/>"/>
SOURCE Jackson GI Medical
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... -- The Institute for In Vitro Sciences (IIVS), a ... a VITROCELL® inhalation exposure system thanks to a generous ... which is designed to replace animals in inhalation testing, ... airborne test materials in an environment that mimics the ... testing combustible tobacco products, as well as next generation ...
(Date:7/6/2017)... July 6, 2017 ThriveRx, the nutrition division of Diplomat Specialty ... to thrive on nutrition support. To celebrate its anniversary, ThriveRx ... has a fresh new look with improved organization to create the best ... ... "We,ve made ...
(Date:7/5/2017)... 5, 2017   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade cell and tissue ... ("BioLife"), today announced that it has reached an agreement ... largest shareholder, to modify its existing credit facility effective ... modification, WAVI agreed to exchange its existing $4.25 million ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... July 19, 2017 , ... Dr. Jig Patel is ... Schaumburg, IL, with or without a referral. Understanding the difficulties that face people who ... when they choose this permanent alternative to removable dentures and bridges. Not only does ...
(Date:7/20/2017)... , ... July 19, 2017 , ... ... $1.5 million Health Resources and Services Administration (HRSA) grant to train predoctoral dental ... health care needs in rural and underserved areas. , The Predoctoral Pediatric Training ...
(Date:7/20/2017)... ... July 19, 2017 , ... ... may sometimes lead to, or worsen, varicose veins in some patients, according to ... while avoiding certain not-so-good practices, like excessive sitting or standing, or regularly nicking ...
(Date:7/18/2017)... Oaks, CA (PRWEB) , ... July 18, 2017 , ... ... Ph.D. scientist extracted cannabis oils, announced today that at the WORLDZ Summit, taking place ... will be speaking on the therapeutic benefits of medical cannabis for both pediatric and ...
(Date:7/18/2017)... Calif. (PRWEB) , ... July 18, 2017 , ... The results of an international clinical ... a drug therapy for a severe type of muscular dystrophy holds promise for a subgroup ... , Craig McDonald and colleagues at 53 study sites in 18 countries describe ...
Breaking Medicine News(10 mins):